Sopharma AD Stock price

Equities

SFA

BG11SOSOBT18

Drug Retailers

End-of-day quote Bulgaria S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
6.24 BGN -1.27% Intraday chart for Sopharma AD -1.89% +9.09%
Sales 2024 * 1.99B 1.1B Sales 2025 * - Capitalization 1.03B 572M
Net income 2024 * 72M 39.82M Net income 2025 * - EV / Sales 2024 * 0.52 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
13.6 x
P/E ratio 2025 *
-
Employees 4,721
Yield 2024 *
4.81%
Yield 2025 *
-
Free-Float 46.35%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.27%
1 week-1.89%
Current month+1.30%
1 month+3.31%
3 months+9.09%
6 months-5.45%
Current year+9.09%
More quotes
1 week
6.24
Extreme 6.24
6.36
1 month
5.94
Extreme 5.94
6.68
Current year
5.58
Extreme 5.58
6.68
1 year
5.05
Extreme 5.05
7.76
3 years
3.28
Extreme 3.28
7.76
5 years
2.40
Extreme 2.4
7.76
10 years
2.40
Extreme 2.4
7.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 00-09-30
Director of Finance/CFO - 01-12-31
Chief Administrative Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 40 00-09-30
Director/Board Member - -
Director/Board Member 60 99-12-31
More insiders
Date Price Change Volume
24-03-27 6.24 -1.27% 11,903
24-03-26 6.32 -0.32% 9,467
24-03-25 6.34 +0.32% 4,297
24-03-22 6.32 -0.32% 2,108
24-03-21 6.34 -0.31% 6,463

End-of-day quote Bulgaria S.E., March 26, 2024

More quotes
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.24 BGN
Average target price
7.14 BGN
Spread / Average Target
+14.42%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Sopharma AD - Bulgaria S.E.